| scholarly article | Q13442814 |
| P2093 | author name string | J Groffen | |
| N Heisterkamp | |||
| V Kaartinen | |||
| Y A DeClerck | |||
| A Lazaryev | |||
| L Blavier | |||
| P2860 | cites work | Expression of the epidermal growth factor receptor in developing fetal mouse palates: an immunohistochemical study | Q68901066 |
| Degradation of cartilage aggrecan by collagenase-3 (MMP-13) | Q71006880 | ||
| Fine structure of mouse secondary palate development in vitro | Q71073615 | ||
| The distribution of epidermal growth factor binding sites in the developing mouse palate | Q72734558 | ||
| Onset of the acquired potentiality for fusion in the palatal shelves of rats | Q72922671 | ||
| MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover | Q73082300 | ||
| Reduced angiogenesis and tumor progression in gelatinase A-deficient mice | Q74309789 | ||
| Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells | Q77221239 | ||
| TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 | Q77357145 | ||
| Murine TIMP-2 gene-targeted mutation | Q78027339 | ||
| Attenuation of oxidant-induced lung injury by the synthetic matrix metalloproteinase inhibitor BB-3103 | Q78027452 | ||
| Biochemical characterization of human collagenase-3 | Q24318765 | ||
| The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction | Q24336413 | ||
| Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage | Q24562729 | ||
| Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas | Q28116247 | ||
| Pathogenesis of cleft palate in TGF-beta3 knockout mice | Q28141234 | ||
| Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction | Q28284617 | ||
| Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase | Q28609377 | ||
| The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study | Q28619177 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| The fate of medial edge epithelial cells during palatal fusion in vitro: an analysis by DiI labelling and confocal microscopy | Q30784811 | ||
| Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci | Q35196271 | ||
| Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells | Q36255048 | ||
| Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function | Q36313391 | ||
| Transforming growth factor-beta 3 is required for secondary palate fusion | Q37373842 | ||
| Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development | Q37386958 | ||
| Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase | Q38330900 | ||
| Palate development | Q39577154 | ||
| Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions | Q40815243 | ||
| Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells | Q41020537 | ||
| Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface | Q41239020 | ||
| ECM and cell surface proteolysis: regulating cellular ecology | Q41656253 | ||
| Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure | Q41663663 | ||
| Differential expression of TGF beta isoforms in murine palatogenesis. | Q41903122 | ||
| Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro | Q42148147 | ||
| Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. | Q42472543 | ||
| Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse | Q42489698 | ||
| Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo | Q43704984 | ||
| Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane | Q44769796 | ||
| Immunodetection of the transforming growth factors beta 1 and beta 2 in the developing murine palate | Q44902866 | ||
| Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor | Q46766121 | ||
| Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. | Q52175351 | ||
| TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. | Q52191961 | ||
| Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. | Q52210294 | ||
| Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes | Q58326928 | ||
| MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells | Q59571869 | ||
| Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase | Q64381116 | ||
| Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation | Q67672314 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1457-1466 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Molecular Biology of the Cell | Q2338259 |
| P1476 | title | TGF-beta3-induced palatogenesis requires matrix metalloproteinases | |
| P478 | volume | 12 |
| Q47881863 | A TGF-beta-induced gene, betaig-h3, is crucial for the apoptotic disappearance of the medial edge epithelium in palate fusion |
| Q39483974 | Ablation of the Sox11 Gene Results in Clefting of the Secondary Palate Resembling the Pierre Robin Sequence |
| Q41781930 | Alteration of medial-edge epithelium cell adhesion in two Tgf-beta3 null mouse strains. |
| Q36838700 | Analysis of Zfhx1a mutant mice reveals palatal shelf contact-independent medial edge epithelial differentiation during palate fusion. |
| Q92570962 | Anterior cleft palate due to Cbfb deficiency and its rescue by folic acid |
| Q36087151 | Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts. |
| Q28507415 | Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart |
| Q46627704 | Cell autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal fusion |
| Q36329382 | Cellular and Molecular Mechanisms of Palatogenesis |
| Q84548187 | Cleft lip and palate |
| Q33671456 | Cleft lip and palate genetics and application in early embryological development |
| Q42439306 | Cleft palate cells can regenerate a palatal mucosa in vitro |
| Q44111674 | Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity |
| Q36857821 | Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling |
| Q48100669 | Computational Model of Secondary Palate Fusion and Disruption. |
| Q41977047 | Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation |
| Q44678396 | Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate. |
| Q38967887 | Deciphering TGF-β3 function in medial edge epithelium specification and fusion during mouse secondary palate development |
| Q57727521 | Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling |
| Q51914657 | Development of secondary palate requires strict regulation of ECM remodeling: sequential distribution of RECK, MMP-2, MMP-3, and MMP-9. |
| Q33614979 | Developmental epigenetics of the murine secondary palate |
| Q46073742 | Drosophila matrix metalloproteinases are required for tissue remodeling, but not embryonic development |
| Q34890656 | Epigenetic analysis of laser capture microdissected fetal epithelia |
| Q36205671 | Epithelial-mesenchymal transformation during craniofacial development. |
| Q92542941 | Extracellular Matrix Composition and Remodeling: Current Perspectives on Secondary Palate Formation, Cleft Lip/Palate, and Palatal Reconstruction |
| Q24297701 | FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex |
| Q33936577 | Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate. |
| Q34125410 | Functional role of TGF-β receptors during palatal fusion in vitro |
| Q28584886 | Functional role of transforming growth factor-beta type III receptor during palatal fusion |
| Q51800972 | Gene-expression analysis of matrix metalloproteinases 1 and 2 and their tissue inhibitors in chronic periapical inflammatory lesions. |
| Q26799998 | Genomic expression in non syndromic cleft lip and palate patients: A review |
| Q36640967 | Heparanase localization during palatogenesis in mice. |
| Q44533433 | Homocysteine oxidation and apoptosis: a potential cause of cleft palate |
| Q43216183 | Human cleft lip and palate fibroblasts and normal nicotine-treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism. |
| Q89849515 | Identification of Smad-dependent and -independent signaling with transforming growth factor-β type 1/2 receptor inhibition in palatogenesis |
| Q36164819 | Induction of palate epithelial mesenchymal transition by transforming growth factor β3 signaling |
| Q37239895 | Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence. |
| Q36321204 | Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy |
| Q38350220 | Intracellular dynamics of Smad‐mediated TGFβ signaling |
| Q28512267 | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development |
| Q89094735 | Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes |
| Q36498019 | Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2. |
| Q80176069 | MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease |
| Q36324816 | MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth |
| Q28592084 | Matrix metalloproteinase-25 has a functional role in mouse secondary palate development and is a downstream target of TGF-β3 |
| Q37407289 | Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo |
| Q52548422 | Matrix metalloproteinases have a role in palatogenesis. |
| Q35893613 | Mechanisms of tissue fusion during development. |
| Q35107597 | Membrane type-matrix metalloproteinases (MT-MMP) |
| Q53625816 | Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. |
| Q34056941 | Mesenchymal cell remodeling during mouse secondary palate reorientation |
| Q36581780 | Molecular control of secondary palate development |
| Q38312474 | Molecular fingerprinting of BMP2- and BMP4-treated embryonic maxillary mesenchymal cells |
| Q38348313 | Molecular fingerprinting of TGFß‐treated embryonic maxillary mesenchymal cells |
| Q35965631 | Molecular, clinical and political approaches to the problem of cleft lip and palate |
| Q34077161 | Novel cleft susceptibility genes in chromosome 6q |
| Q36523170 | Nutrition and genes in the development of orofacial clefting. |
| Q36139769 | Orofacial clefting: recent insights into a complex trait |
| Q46377967 | Overexpression of Smad2 in Tgf-beta3-null mutant mice rescues cleft palate |
| Q28592140 | PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis |
| Q35111595 | Palate morphogenesis: current understanding and future directions |
| Q33597119 | Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions |
| Q31161160 | Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayers |
| Q36325019 | Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice |
| Q24300610 | Regulation of E-cadherin and TGF-beta3 expression by CD24 in cultured oral epithelial cells |
| Q37398452 | Regulation of epithelial-mesenchymal transition in palatal fusion. |
| Q90474996 | Runx1-Stat3-Tgfb3 signaling network regulating the anterior palatal development |
| Q36857755 | Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers. |
| Q34455376 | Site-specific expression of gelatinolytic activity during morphogenesis of the secondary palate in the mouse embryo |
| Q59795774 | TGF-β Signaling and the Epithelial-Mesenchymal Transition during Palatal Fusion |
| Q43678997 | TGFB3 displays parent-of-origin effects among central Europeans with nonsyndromic cleft lip and palate |
| Q35040180 | Tak1, Smad4 and Trim33 redundantly mediate TGF-β3 signaling during palate development |
| Q34294154 | Taking it to the max: the genetic and developmental mechanisms coordinating midfacial morphogenesis and dysmorphology |
| Q36083442 | Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. |
| Q28239297 | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway |
| Q36326693 | Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants |
| Q52085311 | The cellular and molecular etiology of the cleft secondary palate in Fgf10 mutant mice. |
| Q30456163 | The etiology of cleft palate formation in BMP7-deficient mice |
| Q37770097 | The etiology of cleft palate: a 50-year search for mechanistic and molecular understanding |
| Q37383066 | The etiopathogenesis of cleft lip and cleft palate: usefulness and caveats of mouse models |
| Q33725782 | The expression of TGF-β3 for epithelial-mesenchyme transdifferentiated MEE in palatogenesis |
| Q35896486 | The mechanism of TGF-β signaling during palate development |
| Q52086491 | Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression during cardiac neural crest cell migration and its role in proMMP-2 activation. |
| Q36661278 | Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease |
| Q36726025 | Tissue-specific expression of Cre recombinase from the Tgfb3 locus |
| Q24302152 | Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells |
| Q46511382 | Transforming growth factor-beta3 affects plasminogen activator inhibitor-1 expression in fetal mice and modulates fibroblast-mediated collagen gel contraction |
| Q37678707 | Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome |
| Q50568077 | rAAV2-TGF-β(3) decreases collagen synthesis and deposition in the liver of experimental hepatic fibrosis rat. |
Search more.